Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase ...

Greenwich LifeSciences (GLSI), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is ...

Immune response data from FLAMINGO-01 shows positive results in patients with HER2+ breast cancer, suggesting potential for ...

Greenwich LifeSciences (GLSI) stock surges 23% premarket after promising Phase 3 results for GLSI-100, a breast cancer ...

Greenwich LifeSciences (GLSI) announced the following update on FLAMINGO-01 open label immune response data. The company has analyzed the ...

The FLAMINGO-01 DSMB met twice in 2024, most recently in December 2024, and recommended to continue the study as is without modification. No serious adverse events related to GLSI-100 have been ...

HLA_E_group == "High" ~ "High", ...

After several on-again, off-again tariff threats, U.S. President Donald Trump is scheduled later today to announce what is expected to be country-by-country tariffs in an effort to address U.S. trade ...

IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of ...

Latin popstar Danna begins a new chapter as CEO of a boutique label with producer and singer-songwriter Hoyer as chief music officer Latin pop artist Danna was only six years old when she released ...

PBMCs were isolated from collected blood samples using Ficoll–Paque PLUS density gradient centrifugation (GE Healthcare, CA, USA) following the manufacturer’s instructions. Briefly, blood was layered ...